Different pathophysiological abnormalities coexist in individuals with prediabetes, including pancreatic β-cell dysfunction, insulin resistance, reduced incretin effect and lipotoxicity, among others; with pancreatic β-cell dysfunction being a key factor involved in the progression of prediabetes to T2D12–22. The gene discussed is INS; the disease is prediabetes syndrome.